Higher CIP2A expression has been shown as a prognostic factor predicting survival in gastric cancer [29], non-small cell lung cancer [27,45], renal cell carcinoma [46], serous ovarian cancer [47] and early stage tongue cancer [47]. Here, CIP2A is linked to gastric cancer.